OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Release Date
2025
(3)
2023
(2)
2022
(1)
2021
(1)
2020
(1)
2017
(1)
2016
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Diachronic Analysis of the Floristic Diversity of the Special Area of Conservation (SAC) "Bosco di Santo Pietro" (South-Eastern Sicily): A Mediterranean Biodiversity Hotspot.
Not available
S-EPMC11901573
|
biostudies-literature
Cite
A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma.
Not available
S-EPMC8750498
|
biostudies-literature
Cite
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
Not available
S-EPMC3828227
|
biostudies-literature
Cite
Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study.
Not available
S-EPMC8938681
|
biostudies-literature
Cite
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort).
Not available
S-EPMC9967010
|
biostudies-literature
Cite
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.
Not available
S-EPMC12276448
|
biostudies-literature
Cite
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis.
Not available
S-EPMC11741034
|
biostudies-literature
Cite
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Not available
S-EPMC7027476
|
biostudies-literature
Cite
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study.
Not available
S-EPMC5668103
|
biostudies-literature
Cite
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from
CaRe
, a multicentric, observational study.
Not available
S-EPMC10227592
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets